House Bill Updates
View House Bills that pertain to nurse practitioners.
Senate Bill Updates
View Senate Bills that pertain to nurse practitioners.
Notices of Changes or Amendments
Find notices that will directly and significantly impact nurse practitioners.
Comments Submitted on Behalf of PCNP
PCNP Request of Review of Board of Nursing Statement of Policy RN Administration of Conscious Sedation Medication - Submitted Dec. 28, 2018
PCNP Comment on SB780 - Telemedicine Act to Chairman Mustio- Submitted Aug. 27, 2018
PCNP Comment on SB780 - Telemedicine Act to Sen. Vogel - Submitted June 14, 2018
PCNP Comment on Draft OMHSAS Guidelines for the Provision of Tele-Behavioral Health Services - Submitted May 29, 2018
PCNP Comment on CSM Direct Provider Contracting Models - Submitted May 25, 2018
Notices and Upcoming Events
PA Department of Health | 49 Pa.B. 1735 | Renal Disease Advisory Committee Meeting | Notice
The PA Department of Health provided notice that the Renal Disease Advisory Committee will hold its quarterly public meeting on Friday, April 19, 2019, from 10:00 a.m.-1:00 p.m. The purpose of the meeting is to discuss new and ongoing issues relating to treatment of chronic renal disease and the Department of Health's programs related to care and treatment. The meeting will be held in Conference Room 907, Health and Welfare Building, 625 Forster Street, Harrisburg, PA 17120. For additional information, contact Tara Trego, Director, Division of Child and Adult Health Services, 7th Floor East, Health and Welfare Building, 625 Forster Street, Harrisburg, PA 17120, (717) 772-2762.
PA Department of Health | 49 Pa.B. 1734 | Division of Human Immunodeficiency Virus (HIV) Disease Stakeholder Engagement Townhall Meeting | Notice
The Department of Health (Department), Division of HIV Disease, will hold a public meeting on Tuesday, April 23, 2019, from 2:30 p.m.-6:30 p.m. at the Omni William Penn Hotel, 530 William Penn Place, Pittsburgh, PA 15219. This meeting is one of a series of stakeholder engagement meetings being held by the Department that will do the following: (1) allow the Department and the HIV Planning Group (HPG) to interact with a greater number of providers and consumers of HIV prevention and care services and learn more about specific HIV-related needs and organizations in this Commonwealth; (2) provide an opportunity to explain the Integrated HIV Prevention and Care Project (IHPCP) and the work of the HPG to wider and more diverse audiences across this Commonwealth; and (3) record stakeholder and consumer feedback on the IHPCP and current community needs. For additional information, contact Kyle Fait, Special Pharmaceutical Benefits Program, Bureau of Communicable Diseases, Department of Health, Room 611, Health and Welfare Building, 625 Forster Street, Harrisburg, PA 17120, (717) 260-8929.
PA Department of Health | 49 Pa.B. 1857 | Organ Donation Advisory Committee Meeting | Notice
The PA Department of Health (Department) provided notice that the Organ Donation Advisory Committee will hold a public meeting on Thursday, May 2, 2019, from 9:30 a.m. to 3:00 p.m. The purpose of the meeting is to review progress in the area of organ and tissue donation in this Commonwealth, recommend education and awareness activities, recommend priorities in expenditures from the Organ and Tissue Donation Awareness Fund (Fund), and advise the Secretary of Health on matters relating to the administration of the Fund. The meeting will be held at the Gift of Life Donor Program Office, 800 North 3rd Street, Suite 504, Harrisburg, PA 17102. For additional information, contact Amy Flaherty, Director, Division of Nutrition and Physical Activity, Bureau of Health Promotion and Risk Reduction, Room 1000, Health and Welfare Building, Harrisburg, PA, (717) 787-5876.
PA Department of Health | 49 Pa.B. 1856 | Human Immunodeficiency Virus (HIV) Community Prevention Planning Committee Public Meetings | Notice
The PA Department of Health (Department) provided notice that the Statewide HIV Planning Group will hold a public meeting on Wednesday, May 8, 2019, and Thursday, May 9, 2019, from 9:00 a.m.-4:00 p.m. at the Best Western Premier, 800 East Park Drive, Harrisburg, PA 17111. The purpose of these meetings is to conduct an integrated prevention and care HIV planning process by which the Department works in partnership with the community and stakeholders to enhance access to HIV prevention, care and treatment services. For additional information, contact Cynthia Findley, Bureau Director, Department of Health, Bureau of Communicable Diseases, 625 Forster Street, Room 1010, Health and Welfare Building, Harrisburg, PA 17120, (717) 783-0572.
Submit Your Comments to PCNP
The national opioid epidemic is ongoing. As a result, many Senate and House bills are being proposed to address this epidemic, including related to the prescribing of opioids. Two such bills are SB507 and SB112, both of which limit the prescribing of opioids. Please see the below summaries of those bills. By clicking on each bill number, you can review the bill in its entirety. PCNP is requesting your input on these bills and how they could impact your practice should they become law, including providing specific examples of where the proposed legislation could impact you and your patients. Please provide your input on SB507 and SB112 by close of business on May 1, 2019.
SB507 | 2019-2020 Session |Brewster, James (D) | Limit on Prescribing Opioids Per Day
SB507 would be a part of a package of bills to be known as the Drug Prevention Recovery Act to deal with the heroin/opioid epidemic. SB 507 would limit the prescribing of opioids by a prescriber. Under SB507, a prescriber may not prescribe to a patient a combination of opioids in an aggregate amount in excess of 100 morphine milligram equivalents of opioids per day.
Submit your comments to PCNP on SB 507 here.
SB112 | 2019-2020 Session | Yaw, Gene (R) | Prescribing of Opioids – 7 days + Inform Patient of Risks
SB112 would limit the prescription for a controlled substance containing an opioid to 7 days unless there is a medical emergency that puts the patients’ health or safety at risk. SB112 would also require all prescribers who are licensed, registered, or otherwise lawfully authorized to distribute, dispense, or administer a controlled substance containing an opioid to discuss the risks of addiction and dangers of overdose associated with the medication. Previously SB472 of the 2017-2018 Session.
Submit your comments to PCNP on SB 112 here.